Drägerwerk stock gains 1.6 percent as earnings double

Published on 09/22/2026 at 15:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Drägerwerk stock traded at EUR 116.40 on September 22, 2026, after EPS reached EUR 1.58 in Q2. Revenue rose 8.63 percent year over year.

Moderne Intensivstation mit Beatmungsgerät und Patientenmonitoring in klinischer Umgebung — Drägerwerk AG & Co. KGaA zeigt moderne Intensivstation mit Beatmungsgeräten und Patientenmonitoring DE0005550636, Illustration mit AI erstellt.

Drägerwerk stock (ISIN DE0005550636) traded at EUR 116.40 on Xetra at 11:48 a.m. on September 22, 2026, up 1.6 percent during the session. The move followed quarterly figures showing earnings per share of EUR 1.58 for the quarter ended June 30, 2026, compared with EUR 0.61 in the prior-year quarter.

Revenue rises to EUR 847.31 million

According to finanzen.net on September 22, 2026, Drägerwerk reported revenue of EUR 847.31 million for the quarter ended June 30, 2026. That was 8.63 percent above EUR 779.99 million in the same quarter of 2025, while quarterly EPS increased by EUR 0.97, or about 159 percent, from EUR 0.61 to EUR 1.58.

The comparison matters because the share price was already close to its yearly high. Drägerwerk opened the Xetra session at EUR 114.60 and reached EUR 116.60 intraday, placing the EUR 116.40 quote EUR 0.60 below the 52-week high of EUR 117.00 recorded on September 1, 2026.

Margin expectations meet valuation

MarketScreener lists an average analyst target of EUR 109.00 and a mean consensus rating of Outperform based on five analysts, with the last close shown at EUR 114.60 on September 22, 2026. The target therefore stood EUR 5.60, or 4.88 percent, below that reference close, creating a valuation counterweight to the positive earnings comparison.

The same data set shows estimated 2026 net sales of EUR 3.63 billion and estimated net income of EUR 149 million. These are estimates rather than reported quarterly results, so the reported Q2 figures remain the cleaner measure of the latest operating performance.

Q3 date sets the next checkpoint

MarketScreener lists October 29, 2026 as the next earnings release date for Q3 2026. That date gives the market a defined checkpoint for testing whether the 8.63 percent revenue growth and the EPS increase from EUR 0.61 to EUR 1.58 continue into the second half of the year.

Stock stays near 52-week high

At EUR 116.40 on Xetra as of September 22, 2026 at 11:48 a.m., Drägerwerk stock was EUR 53.90 above its 52-week low of EUR 62.50 recorded on October 1, 2025, and EUR 0.60 below its 52-week high of EUR 117.00. Xetra volume stood at 3,333 shares at the quoted time.